# US 2010/0168075 A1 · Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168075 A1
- Document ID: US20100168075A1
- Status: Published application
- Kind: A1
- Application number: 11/993,470
- Filed: 2006-06-21
- Published: 2010-07-01
- Earliest claimed: 2005-06-22
- Assignees: AstraZeneca AB
- Inventors: Mikael Dahlstrom; Fana Hunegnaw; Malin Lemurell; Peter Nordberg; Tore Skjaret; Ingemar Starke
- Web page: https://patentgrep.com/patent/US20100168075A1

## CPC

- C07D 205/08: with one oxygen atom directly attached in position 2, e.g. beta-lactams
- A61P 3/06: Antihyperlipidemics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The application relates to novel 2-azetidinone derivatives of formula (I) and pharmaceutically acceptable salts, solvates and prodrugs thereof. The compounds are cholesterol absorption inhibitors and are useful in the treatment of hyperlipidaemic conditions, including atherosclerosis, Alzheimers' disease and cholesterol associated tumours. The application also relates to pharmaceutical formulations comprising such compounds and to processes for their preparation.

## Claims

### Claim 1

A compound of formula (I):
wherein:
R1 and R2 are, independently, hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl of and C1-6alkoxy;
R3 is halo, hydroxy, C1-6alkyl, C1-6alkoxy or C1-6alkylS(O)a wherein a is 0 to 2; wherein R3 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy or hydroxy;
R4 is halo, nitro, cyano, hydroxy, amino, carboxy, formyl, carbamoyl, carbamoyloxy, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkenyloxy, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl-N-(C1-6alkyl)amino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkyl)carbamoyloxy, N,N-(C1-6alkyl)2carbamoyloxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, C1-6alkoxycarbonyl-N-(C1-6alkyl)amino, C1-6alkoxycarbonyloxy, C1-6alkoxycarbonylamino, ureido, N′-(C1-6alkyl)ureido, N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2ureido, N′-(C1-6alkyl)-N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2-N-(C1-6alkyl)ureido, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl or phenyl; wherein R4 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy, hydroxy, amino, carboxy, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, phenyl, phenoxy, benzoyl, phenylC1-6alkyl or phenylC1-6alkoxy;
R5 is hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R29-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R30-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR31)(OR32), —P(O)(OH)(OR31), —P(O)(OH)(R31) or —P(O)(OR31)(R32) wherein R31 and R32 are independently selected from C1-6alkyl; wherein R5 may be optionally substituted on carbon by one or more R33; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R34;
or R5 is a group of formula (IA):
wherein:
Z is —N(R35)—, —N(R35)C(O)—, —O—, or —S(O)a—; wherein a is 0-2 and R35 is hydrogen or C1-4alkyl;
R15 is hydrogen or C1-4alkyl;
R16 and R17 are independently selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR36)(OR37), —P(O)(OH)(OR36), —P(O)(OH)(R36) and —P(O)(OR36)(R37), wherein R36 and R37 are independently selected from C1-6alkyl; wherein R16 and R17 may be independently optionally substituted on carbon by one or more R38; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R39;
R18 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, C1-10alkoxycarbonyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R40-(C1-10alkylene)f- or heterocyclyl-(C1-10alkylene)g-R41-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR42)(OR43), —P(O)(OH)(OR42), —P(O)(OH)(R42) and —P(O)(OR42)(R43) wherein R42 and R43 are independently selected from C1-6alkyl; wherein R18 may be optionally substituted on carbon by one or more R44; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R45;
or R18 is a group of formula (IB):
wherein:
R19 is hydrogen or C1-4alkyl;
R20 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR46)(OR47), —P(O)(OH)(OR46), —P(O)(OH)(R46) and —P(O)(OR46)(R47), wherein R46 and R47 are independently selected from C1-6alkyl; where R20 may be independently optionally substituted on carbon by one or more R48; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R49;
R21 is selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R50-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R51-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR52)(OR53), —P(O)(OH)(OR52), —P(O)(OH)(R52) and —P(O)(OR53)(R53) wherein R52 and R53 are independently selected from C1-6alkyl; wherein R21 may be independently optionally substituted on carbon by one or more R54; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R55;
p is 1-3; wherein the values of R16 may be the same or different;
q is 0-1;
r is 0-3; wherein the values of R17 may be the same or different;
z is 0-3; wherein the values of R20 may be the same or different;
R33, R38, R44, R48 and R54 are independently selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, C1-10alkoxycarbonyl, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R56-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R57-(C1-10alkylene)h-, carboxy, sulpho, sulphino, amidino, phosphono, —P(O)(OR58)(OR59), —P(O)(OH)(OR58), —P(O)(OH)(R58) and —P(O)(OR59)(R59), wherein R58 and R59 are independently selected from C1-6alkyl; wherein R33, R38, R44, R48 and R54 may be independently optionally substituted on carbon by one or more R60; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R61;
R34, R39, R45, R49, R55 and R61 are independently selected from C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, sulphamoyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, benzyl, phenethyl, benzoyl, phenylsulphonyl and phenyl;
R29, R30, R40, R41, R50, R51, R56 and R57 are independently selected from —O—, —NR62—, —S(O)x—, —NR62C(O)NR63—, —NR62C(S)NR63—, —OC(O)N═C—, —NR62C(O)— and —C(O)NR62—; wherein R62 and R63 are independently selected from hydrogen and C1-6alkyl, and x is 0-2;
R60 is selected from halo, hydroxy, cyano, carbamoyl, ureido, amino, nitro, carboxy, carbamoyl, mercapto, sulphamoyl, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, ethoxy, vinyl, allyl, ethynyl, methoxycarbonyl, formyl, acetyl, formamido, acetylamino, acetoxy, methylamino, dimethylamino, N-methylcarbamoyl, N,N-dimethylcarbamoyl, methylthio, methylsulphinyl, mesyl, N-methylsulphamoyl and N,N-dimethylsulphamoyl; and
e, f, g and h are independently selected from 0-2;
R6 is hydrogen, alkyl, c-alkyl or aryl; and
c is 1, 2, 3, 4 or 5;
or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof;
provided that compounds of formula (I) are not compounds of formula A
wherein:
R1 is hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R2 and R5 are independently hydrogen, a branched or unbranched C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, cyano, carbamoyl, carboxy, C1-6alkoxy, aryl C1-6alkoxy, (C1-C4alkyl)3Si, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkylS(O)a, C1-6alkanoylamino, C3-6cycloalkyl, aryl or aryl C1-6alkylS(O)a, wherein a is 0-2; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R3 is hydrogen, alkyl, halo, C1-6alkoxy or C1-6alkylS—;
R4 is hydrogen, C1-6alkyl, halo or C1-6alkoxy; and
R6 is hydrogen, C1-6alkyl, or arylC1-6alkyl;
wherein R5 and R2 may form a ring with 2-7 carbon atoms and wherein R6 and R2 may form a ring with 3-6 carbon atoms;
or N-{[4-((2R,3R)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxo-1-phenylazetidin-2-yl)phenoxy]acetyl}glycine.

### Claim 2

A compound of formula (I2):
wherein:
R1 and R2 are, independently, hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R3 is halo, hydroxy, C1-6alkyl, C1-6alkoxy or C1-6alkylS(O)a wherein a is 0 to 2; wherein
R3 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy or hydroxy;
R4 is halo, nitro, cyano, hydroxy, amino, carboxy, formyl, carbamoyl, carbamoyloxy, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkenyloxy, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl-N-(C1-6alkyl)amino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkyl)carbamoyloxy, N,N-(C1-6alkyl)2carbamoyloxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, C1-6alkoxycarbonyl-N-(C1-6alkyl)amino, C1-6alkoxycarbonyloxy, C1-6alkoxycarbonylamino, ureido, N′-(C1-6alkyl)ureido, N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2ureido, N′-(C1-6alkyl)-N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2-N-(C1-6alkyl)ureido, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl or phenyl; wherein R4 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy, hydroxy, amino, carboxy, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, phenyl, phenoxy, benzoyl, phenylC1-6alkyl or phenylC1-6alkoxy;
R5 is hydrogen, halo, nitro, cyano, hydroxy, amino, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R29-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R30-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR31)(OR32), —P(O)(OH)(OR31), —P(O)(OH)(R31) or —P(O)(OR31)(R32) wherein R31 and R32 are independently selected from C1-6alkyl; wherein R5 may be optionally substituted on carbon by one or more R33; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R34;
or R5 is a group of formula (IA):
wherein:
Z is —N(R35)—, —N(R35)C(O)—, —O—, or —S(O)a—; wherein a is 0-2 and R35 is hydrogen or C1-4alkyl;
R15 is hydrogen or C1-4alkyl;
R16 and R17 are independently selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR36)(OR37), —P(O)(OH)(OR36), —P(O)(OH)(R36) and —P(O)(OR36)(R37), wherein R36 and R37 are independently selected from C1-6alkyl; wherein R16 and R17 may be independently optionally substituted on carbon by one or more R38; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R39;
R18 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, C1-10alkoxycarbonyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R40-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R41-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR42)(OR43), —P(O)(OH)(OR42), —P(O)(OH)(R42) and —P(O)(OR42)(R43) wherein R42 and R43 are independently selected from C1-6alkyl; wherein R18 may be optionally substituted on carbon by one or more R44; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R45;
or R18 is a group of formula (IB):
wherein:
R19 is hydrogen or C1-4alkyl;
R20 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR46)(OR47), —P(O)(OH)(OR46), —P(O)(OH)(R46) and —P(O)(OR46)(R47), wherein R46 and R47 are independently selected from C1-6alkyl; where R20 may be independently optionally substituted on carbon by one or more R48; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R49;
R21 is selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R50-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R51-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR52)(OR53), —P(O)(OH)(OR52), —P(O)(OH)(R52) and —P(O)(OR53)(R53) wherein R52 and R53 are independently selected from C1-6alkyl; wherein R21 may be independently optionally substituted on carbon by one or more R54; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R55;
p is 1-3; wherein the values of R16 may be the same or different;
q is 0-1;
r is 0-3; wherein the values of R17 may be the same or different;
z is 0-3; wherein the values of R20 may be the same or different;
R33, R38, R44, R48 and R54 are independently selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, C1-10alkoxycarbonyl, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino N,N,N-(C1-10alkyl)3ammonio C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R56-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)g-R57-(C1-10alkylene)h-, carboxy, sulpho, sulphino, amidino, phosphono, —P(O)(OR58)(OR59), —P(O)(OH)(OR58), —P(O)(OH)(R58) and —P(O)(OR59)(R59), wherein R58 and R59 are independently selected from C1-6alkyl; wherein R33, R38, R44, R48 and R54 may be independently optionally substituted on carbon by one or more R60; and
wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R61;
R34, R39, R45, R49, R55 and R61 are independently selected from C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, sulphamoyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, benzyl, phenethyl, benzoyl, phenylsulphonyl and phenyl;
R29, R30, R40, R41, R50, R51, R56 and R57 are independently selected from —O—, —NR62—, —S(O)x—, —NR62C(O)NR63—, —NR62C(S)NR63—, —OC(O)N═C—, —NR62C(O)— and —C(O)NR62—; wherein R62 and R63 are independently selected from hydrogen and C1-6alkyl, and x is 0-2;
R60 is selected from halo, hydroxy, cyano, carbamoyl, ureido, amino, nitro, carboxy, carbamoyl, mercapto, sulphamoyl, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, ethoxy, vinyl, allyl, ethynyl, methoxycarbonyl, formyl, acetyl, formamido, acetylamino, acetoxy, methylamino, dimethylamino, N-methylcarbamoyl, N,N-dimethylcarbamoyl, methylthio, methylsulphinyl, mesyl, N-methylsulphamoyl and N,N-dimethylsulphamoyl; and
e, f, g and h are independently selected from 0-2;
R6 is hydrogen, alkyl, c-alkyl or aryl;
c is 1, 2, 3, 4 or 5;
or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof;
provided that compounds of formula (I2) are not compounds of formula A
wherein:
R1 is hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R2 and R5 are independently hydrogen, a branched or unbranched C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, cyano, carbamoyl, carboxy, C1-6alkoxy, aryl C1-6alkoxy, (C1-C4 alkyl)3Si, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkylS(O)a, C1-6alkanoylamino, C3-6cycloalkyl, aryl or aryl C1-6alkylS(O)a, wherein a is 0-2; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R3 is hydrogen, alkyl, halo, C1-6alkoxy or C1-6alkylS—;
R4 is hydrogen, C1-6alkyl, halo or C1-6alkoxy; and
R6 is hydrogen, C1-6alkyl, or arylC1-6alkyl;
wherein R5 and R2 may form a ring with 2-7 carbon atoms and wherein R6 and R2 may form a ring with 3-6 carbon atoms;
or N-{[4-((2R,3R)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxo-1-phenylazetidin-2-yl)phenoxy]acetyl}glycine.

### Claim 3 (depends on 1)

A compound according to claim 1, wherein: R1 is hydrogen.

### Claim 4 (depends on 1)

A compound according to claim 1, wherein: R2 is halo or methoxy.

### Claim 5 (depends on 1)

A compound according to claim 1, wherein: R2 is chlorine or fluorine.

### Claim 6 (depends on 1)

A compound according to claim 1, wherein R1 and R2 form a five-membered ring containing one oxygen.

### Claim 7 (depends on 1)

A compound according to claim 1, wherein R1 and R2 form a six-membered ring containing two oxygens.

### Claim 8 (depends on 1)

A compound according to claim 1, wherein: R3 is hydrogen.

### Claim 9 (depends on 1)

A compound according to claim 1, wherein: R4 is halo.

### Claim 10 (depends on 1)

A compound according to claim 1, wherein: R6 is hydrogen.

### Claim 11

One or more compounds selected from:
(3R)-3-[(N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl)amino]-4-phenylbutanoic acid;
3-cyclohexyl-3-[(N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-hydroxy-2-(4-methoxyphenyl)ethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl)amino]propanoic acid;
2-[(N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl)amino]ethanesulfonic acid;
N6-(N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl)-D-lysine;
N-{2-[(N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl)amino]ethyl}-D-valine;
3-[(N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl)amino]-4,4-dimethylpentanoic acid;
N-[2-({[4-((2R,3R)-1-(4-fluorophenyl)-3-{[2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}amino)ethyl]-D-valine; and
N-{[4-((2R,3R)-1-(4-fluorophenyl)-3-{[(2R or S)-2-(4-fluorophenyl)-2-hydroxyethyl]thio}-4-oxoazetidin-2-yl)phenoxy]acetyl}glycyl-3-cyclohexyl-N-(2-sulfoethyl)-D-alaninamide.

### Claim 12 (depends on 1)

A method of treating or preventing hyperlipidemic conditions comprising the administration of an effective amount of a compound according to claim 1 to a mammal in need thereof.

### Claim 13 (depends on 1)

A method of treating or preventing atherosclerosis comprising the administration of an effective amount of a compound according to claim 1 to a mammal in need thereof.

### Claim 14 (depends on 1)

A method for treating or preventing Alzheimers' disease comprising the administration of an effective amount of a compound according to claim 1 to a mammal in need thereof.

### Claim 15 (depends on 1)

A method for treating or preventing cholesterol associated tumors comprising the administration of an effective amount of a compound according to claim 1 to a mammal in need thereof.

### Claim 16 (depends on 1)

A pharmaceutical formulation comprising a compound according to claim 1 in admixture with a pharmaceutically acceptable adjuvant, diluent and/or carrier.

### Claim 17

A combination of a compound according to formula (I) or (I2)
wherein:
R1 and R2 are, independently, hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R3 is halo, hydroxy, C1-6alkyl, C1-6alkoxy or C1-6alkylS(O)a wherein a is 0 to 2; wherein R3 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy or hydroxy;
R4 is halo, nitro, cyano, hydroxy, amino, carboxy, formyl, carbamoyl, carbamoyloxy, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkenyloxy, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl-N-(C1-6alkyl)amino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkyl)carbamoyloxy, N,N-(C1-6alkyl)2carbamoyloxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, C1-6alkoxycarbonyl-N-(C1-6alkyl)amino, C1-6alkoxycarbonyloxy, C1-6alkoxycarbonylamino, ureido, N′-(C1-6alkyl)ureido, N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2ureido, N′-(C1-6alkyl)-N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2-N-(C1-6alkyl)ureido, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl or phenyl; wherein R4 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy, hydroxy, amino, carboxy, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, phenyl, phenoxy, benzoyl, phenylC1-6alkyl or phenylC1-6alkoxy;
R5 is hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R29-(C1-10alkylene)f, heterocyclyl-(C1-10alkylene)a-R30-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR31)(OR32), —P(O)(OH)(OR31), —P(O)(OH)(R31) or —P(O)(OR31)(R32) wherein R31 and R32 are independently selected from C1-6alkyl; wherein R5 may be optionally substituted on carbon by one or more R33; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R34;
or R5 is a group of formula (IA):
wherein:
Z is —N(R35)—, —N(R35)C(O)—, —O—, or —S(O)a—; wherein a is 0-2 and R35 is hydrogen or C1-4 alkyl;
R15 is hydrogen or C1-4alkyl;
R16 and R17 are independently selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR36)(OR37), —P(O)(OH)(OR36), —P(O)(OH)(R36) and —P(O)(OR36)(R37), wherein R36 and R37 are independently selected from C1-6alkyl; wherein R16 and R17 may be independently optionally substituted on carbon by one or more R38; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R39;
R18 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, C1-10alkoxycarbonyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R40-(C1-10-alkylene)f- or heterocyclyl-(C1-10alkylene)a-R41-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR42)(OR43), —P(O)(OH)(OR42), —P(O)(OH)(R42) and —P(O)(OR42)(R43) wherein R42 and R43 are independently selected from C1-6alkyl; wherein R18 may be optionally substituted on carbon by one or more R44; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R45;
or R18 is a group of formula (IB):
wherein:
R19 is selected from hydrogen and C1-4alkyl;
R20 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR46)(OR47), —P(O)(OH)(OR46), —P(O)(OH)(R46) and —P(O)(OR46)(R47), wherein R46 and R47 are independently selected from C1-6alkyl; where R20 may be independently optionally substituted on carbon by one or more R48; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R49;
R21 is selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R59-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)a-R51-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR52)(OR53), —P(O)(OH)(OR52), —P(O)(OH)(R52) and —P(O)(OR53)(R53) wherein R52 and R53 are independently selected from C1-6alkyl; wherein R21 may be independently optionally substituted on carbon by one or more R54; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R55;
p is 1-3; wherein the values of R16 may be the same or different;
q is 0-1;
r is 0-3; wherein the values of R17 may be the same or different;
z is 0-3; wherein the values of R29 may be the same or different;
R33, R38, R44, R48 and R54 are independently selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, C1-10alkoxycarbonyl, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R56-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)z-R57-(C1-10alkylene)h-, carboxy, sulpho, sulphino, amidino, phosphono, —P(O)(OR58)(OR59), —P(O)(OH)(OR58), —P(O)(OH)(R58) and —P(O)(OR59)(R59), wherein R58 and R59 are independently selected from C1-6alkyl; wherein R33, R38, R44, R48 and R54 may be independently optionally substituted on carbon by one or more R69; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R61;
R34, R39, R45, R49, R55 and R61 are independently selected from C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, sulphamoyl, N-(C1-6alkyl)sulphamoyl, N-(C1-6alkyl)2sulphamoyl, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, benzyl, phenethyl, benzoyl, phenylsulphonyl and phenyl;
R29, R30, R40, R41, R50, R51, R56 and R57 are independently selected from —O—, —NR62—, —S(O)x—, —NR62C(O)NR63—, —NR62C(S)NR63—, —OC(O)N═C—, —NR62C(O)— and —C(O)NR62—;
wherein R62 and R63 are independently selected from hydrogen and C1-6alkyl, and x is 0-2;
R60 is selected from halo, hydroxy, cyano, carbamoyl, ureido, amino, nitro, carboxy, carbamoyl, mercapto, sulphamoyl, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, ethoxy, vinyl, allyl, ethynyl, methoxycarbonyl, formyl, acetyl, formamido, acetylamino, acetoxy, methylamino, dimethylamino, N-methylcarbamoyl, N,N-dimethylcarbamoyl, methylthio, methylsulphinyl, mesyl, N-methylsulphamoyl and N,N-dimethylsulphamoyl;
e, f, g and h are independently selected from 0-2;
R6 is hydrogen, alkyl, c-alkyl or aryl; and
c is 1, 2, 3, 4 or 5;
or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof;
with a PPAR alpha and/or gamma agonist.

### Claim 18

A combination of a compound according to formula (I) or (I2)
wherein:
R1 and R2 are, independently, hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R3 is halo, hydroxy, C1-6alkyl, C1-6alkoxy or C1-6alkylS(O)a wherein a is 0 to 2; wherein R3 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy or hydroxy;
R4 is halo, nitro, cyano, hydroxy, amino, carboxy, formyl, carbamoyl, carbamoyloxy, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkenyloxy, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl-N-(C1-6alkyl)amino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkyl)carbamoyloxy, N,N-(C1-6alkyl)2carbamoyloxy, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, C1-6alkoxycarbonyl-N-(C1-6alkyl)amino, C1-6alkoxycarbonyloxy, C1-6alkoxycarbonylamino, ureido, N′-(C1-6alkyl)ureido, N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2ureido, N′-(C1-6alkyl)-N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2-N-(C1-6alkyl)ureido, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl or phenyl; wherein R4 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy, hydroxy, amino, carboxy, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, phenyl, phenoxy, benzoyl, phenylC1-6alkyl or phenylC1-6alkoxy;
R5 is hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R29-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)a-R30-(C1-10alkylene)h, carboxy, sulpho, sulphino, phosphono, —P(O)(OR31)(OR32), —P(O)(OH)(OR31), —P(O)(OH)(R31) or —P(O)(OR31)(R32) wherein R31 and R32 are independently selected from C1-6alkyl; wherein R5 may be optionally substituted on carbon by one or more R33; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R34;
or R5 is a group of formula (IA):
wherein:
Z is —N(R35)—, —N(R35)C(O)—, —O—, or —S(O)a—; wherein a is 0-2 and R35 is hydrogen or C1-4 alkyl;
R15 is hydrogen or C1-4alkyl;
R16 and R17 are independently selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O), wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR36)(OR37), —P(O)(OH)(OR36), —P(O)(OH)(R36) and —P(O)(OR36)(R37), wherein R36 and R37 are independently selected from C1-6alkyl; wherein R16 and R17 may be independently optionally substituted on carbon by one or more R38; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R39;
R18 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, C1-10alkoxycarbonyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R40-(C1-10-alkylene)f- or heterocyclyl-(C1-10alkylene)a-R41-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR42)(OR43), —P(O)(OH)(OR42), —P(O)(OH)(R42) and —P(O)(OR42)(R43) wherein R42 and R43 are independently selected from C1-6alkyl; wherein R18 may be optionally substituted on carbon by one or more R44; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R45;
or R18 is a group of formula (IB):
wherein:
R19 is hydrogen or C1-4alkyl;
R20 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR46)(OR47), —P(O)(OH)(OR46), —P(O)(OH)(R46) and —P(O)(OR46)(R47), wherein R46 and R47 are independently selected from C1-6alkyl; where R20 may be independently optionally substituted on carbon by one or more R48;
and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R49;
R21 is selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R50-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)z-R51-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR52)(OR53), —P(O)(OH)(OR52), —P(O)(OH)(R52) and —P(O)(OR53)(R53) wherein R52 and R53 are independently selected from C1-6alkyl; wherein R21 may be independently optionally substituted on carbon by one or more R54; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R55;
p is 1-3; wherein the values of R16 may be the same or different;
q is 0-1;
r is 0-3; wherein the values of R17 may be the same or different;
z is 0-3; wherein the values of R20 may be the same or different;
R33, R38, R44, R48 and R54 are independently selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, C1-10alkoxycarbonyl, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R56-(C1-10alkylene) heterocyclyl-(C1-10alkylene)z-R57-(C1-10alkylene)h-, carboxy, sulpho, sulphino, amidino, phosphono, —P(O)(OR58)(OR59), —P(O)(OH)(OR58), —P(O)(OH)(R58) and —P(O)(OR59)(R59), wherein R58 and R59 are independently selected from C1-6alkyl; wherein R33, R38, R44, R48 and R54 may be independently optionally substituted on carbon by one or more R69; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R61;
R34, R39, R45, R49, R55 and R61 are independently selected from C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, sulphamoyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, benzyl, phenethyl, benzoyl, phenylsulphonyl and phenyl;
R29, R30, R40, R41, R50, R51, R56 and R57 are independently selected from —O—, —NR62—, —S(O)x—, —NR62C(O)NR63—, —NR62C(S)NR63—, —OC(O)N═C—, —NR62C(O)— and —C(O)NR62—; wherein R62 and R63 are independently selected from hydrogen and C1-6alkyl, and x is 0-2;
R69 is selected from halo, hydroxy, cyano, carbamoyl, ureido, amino, nitro, carboxy, carbamoyl, mercapto, sulphamoyl, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, ethoxy, vinyl, allyl, ethynyl, methoxycarbonyl, formyl, acetyl, formamido, acetylamino, acetoxy, methylamino, dimethylamino, N-methylcarbamoyl, N,N-dimethylcarbamoyl, methylthio, methylsulphinyl, mesyl, N-methylsulphamoyl and N,N-dimethylsulphamoyl;
e, f, g and h are independently selected from 0-2;
R6 is hydrogen, alkyl, c-alkyl or aryl; and
c is 1, 2, 3, 4 or 5;
or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof;
with an HMG Co-A reductase inhibitor.

### Claim 19

A process for preparing a compound of formula (I)
wherein:
R1 and R2 are, independently, hydrogen, C1-6alkyl, C3-6cycloalkyl or aryl; wherein said C1-6alkyl may be optionally substituted by one or more hydroxy, amino, guanidino, carbamoyl, carboxy, C1-6alkoxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-C6alkylcarbonylamino, C1-6alkylS(O)a wherein a is 0-2, C3-6cycloalkyl or aryl; and wherein any aryl group may be optionally substituted by one or two substituents selected from halo, hydroxy, C1-6alkyl and C1-6alkoxy;
R3 is halo, hydroxy, C1-6alkyl, C1-6alkoxy or C1-6alkylS(O)a wherein a is 0 to 2; wherein R3 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy or hydroxy;
R4 is halo, nitro, cyano, hydroxy, amino, carboxy, formyl, carbamoyl, carbamoyloxy, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkenyloxy, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl-N-(C1-6alkyl)amino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, N-(C1-6alkyl)carbamoyloxy, N,N-(C1-6alkyl)2carbamoyloxy, C1-6alkylS(O), wherein a is 0 to 2, C1-6alkoxycarbonyl, C1-6alkoxycarbonylamino, C1-6alkoxycarbonyl-N-(C1-6alkyl)amino, C1-6alkoxycarbonyloxy, C1-6alkoxycarbonylamino, ureido, C1-6alkyl)ureido, N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2ureido, N′-(C1-6alkyl)-N-(C1-6alkyl)ureido, N′,N′-(C1-6alkyl)2-N-(C1-6alkyl)ureido, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl or phenyl; wherein R4 is independently optionally substituted on carbon by one or more halo, C1-6alkoxy, hydroxy, amino, carboxy, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkanoylamino, C1-6alkanoyl-N-(C1-6alkyl)amino, phenyl, phenoxy, benzoyl, phenylC1-6alkyl or phenylC1-6alkoxy;
R5 is hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R29-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)z-R30-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR31)(OR32), —P(O)(OH)(OR31), —P(O)(OH)(R31) or —P(O)(OR31)(R32) wherein R31 and R32 are independently selected from C1-6alkyl; wherein R5 may be optionally substituted on carbon by one or more R33; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R34;
or R5 is a group of formula (IA):
wherein:
Z is —N(R35)—, —N(R35)C(O)—, —O—, or —S(O)a—; wherein a is 0-2 and R35 is hydrogen or C1-4 alkyl;
R15 is hydrogen or C1-4alkyl;
R16 and R17 are independently selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR36)(OR37), —P(O)(OH)(OR36), —P(O)(OH)(R36) and —P(O)(OR36)(R37), wherein R36 and R37 are independently selected from C1-6alkyl; wherein R16 and R17 may be independently optionally substituted on carbon by one or more R38; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R39;
R18 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, C1-10alkoxycarbonyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R40-(C1-10-alkylene)f- or heterocyclyl-(C1-10alkylene)a-R41-(C1-10alkylene)h-n carboxy, sulpho, sulphino, phosphono, —P(O)(OR42)(OR43), —P(O)(OH)(OR42), —P(O)(OH)(R42) and —P(O)(OR42)(R43) wherein R42 and R43 are independently selected from C1-6alkyl; wherein R18 may be optionally substituted on carbon by one or more R44; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R45;
or R18 is a group of formula (IB):
wherein:
R19 is hydrogen or C1-4alkyl;
R20 is selected from hydrogen, halo, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, mercapto, sulphamoyl, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, C1-6alkanoyl, C1-6alkanoyloxy, N-(C1-6alkyl)amino, N,N-(C1-6alkyl)2amino, C1-6alkanoylamino, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, C1-6alkylS(O)a wherein a is 0 to 2, C1-6alkoxycarbonyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, carbocyclyl, heterocyclyl, sulpho, sulphino, amidino, phosphono, —P(O)(OR46)(OR47), —P(O)(OH)(OR46), —P(O)(OH)(R46) and —P(O)(OR46)(R47), wherein R46 and R47 are independently selected from C1-6alkyl; where R20 may be independently optionally substituted on carbon by one or more R48;
and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R49;
R21 is selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkoxycarbonyl, C1-10alkanoyl, C1-10alkanoyloxy, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R50-(C1-10alkylene) heterocyclyl-(C1-10alkylene)a-R51-(C1-10alkylene)h-, carboxy, sulpho, sulphino, phosphono, —P(O)(OR52)(OR53), —P(O)(OH)(OR52), —P(O)(OH)(R52) and —P(O)(OR53)(R53) wherein R52 and R53 are independently selected from C1-6alkyl; wherein R21 may be independently optionally substituted on carbon by one or more R54; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R55;
p is 1-3; wherein the values of R16 may be the same or different;
q is 0-1;
r is 0-3; wherein the values of R17 may be the same or different;
z is 0-3; wherein the values of R20 may be the same or different;
R33, R38, R44, R48 and R54 are independently selected from halo, nitro, cyano, hydroxy, amino, carbamoyl, mercapto, sulphamoyl, hydroxyaminocarbonyl, C1-10alkyl, C2-10alkenyl, C2-10alkynyl, C1-10alkoxy, C1-10alkanoyl, C1-10alkanoyloxy, C1-10alkoxycarbonyl, N-(C1-10alkyl)amino, N,N-(C1-10alkyl)2amino, N,N,N-(C1-10alkyl)3ammonio, C1-10alkanoylamino, N-(C1-10alkyl)carbamoyl, N,N-(C1-10alkyl)2carbamoyl, C1-10alkylS(O)a wherein a is 0 to 2, N-(C1-10alkyl)sulphamoyl, N,N-(C1-10alkyl)2sulphamoyl, N-(C1-10alkyl)sulphamoylamino, N,N-(C1-10alkyl)2sulphamoylamino, C1-10alkoxycarbonylamino, carbocyclyl, carbocyclylC1-10alkyl, heterocyclyl, heterocyclylC1-10alkyl, carbocyclyl-(C1-10alkylene)e-R56-(C1-10alkylene)f-, heterocyclyl-(C1-10alkylene)a-R57-(C1-10alkylene)h-, carboxy, sulpho, sulphino, amidino, phosphono, —P(O)(OR58)(OR59), —P(O)(OH)(OR58), —P(O)(OH)(R58) and —P(O)(OR59)(R59), wherein R58 and R59 are independently selected from C1-6alkyl; wherein R33, R38, R44, R48 and R54 may be independently optionally substituted on carbon by one or more R60; and wherein if said heterocyclyl contains an —NH— group, that nitrogen may be optionally substituted by R61;
R34, R39, R45, R49, R55 and R61 are independently selected from C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, sulphamoyl, N-(C1-6alkyl)sulphamoyl, N,N-(C1-6alkyl)2sulphamoyl, C1-6alkoxycarbonyl, carbamoyl, N-(C1-6alkyl)carbamoyl, N,N-(C1-6alkyl)2carbamoyl, benzyl, phenethyl, benzoyl, phenylsulphonyl and phenyl;
R29, R30, R40, R41, R50, R51, R56 and R57 are independently selected from —O—, —NR62—, —S(O)x—, —NR62C(O)NR63—, —NR62C(S)NR63—, —OC(O)N═C—, —NR62C(O)— and —C(O)NR62—; wherein R62 and R63 are independently selected from hydrogen and C1-6alkyl, and x is 0-2;
R60 is selected from halo, hydroxy, cyano, carbamoyl, ureido, amino, nitro, carboxy, carbamoyl, mercapto, sulphamoyl, trifluoromethyl, trifluoromethoxy, methyl, ethyl, methoxy, ethoxy, vinyl, allyl, ethynyl, methoxycarbonyl, formyl, acetyl, formamido, acetylamino, acetoxy, methylamino, dimethylamino, N-methylcarbamoyl, N,N-dimethylcarbamoyl, methylthio, methylsulphinyl, mewl, N-methylsulphamoyl and N,N-dimethylsulphamoyl;
e, f, g and h are independently selected from 0-2;
R6 is hydrogen, alkyl, c-alkyl or aryl; and
c is 1, 2, 3, 4 or 5;
or a pharmaceutically acceptable salt, solvate, solvate of such a salt or a prodrug thereof which process (wherein variable groups are, unless otherwise specified, as defined in formula (I)) comprising any of the steps of:
Process 1) reacting a compound of formula (II):
with a compound of formula (III):
wherein L is a displaceable group; or
Process 2) reacting an acid of formula (IV):
or an activated derivative thereof; with an amine of formula (V):
or
Process 3): reducing a compound of formula (VI):
or
Process 4): reacting a compound of formula (VII):
with a compound of formula (VIII):
wherein L is a displaceable group; or
Process 5): reacting a compound of formula (IX):
wherein L is a displaceable group; with a compound of formula (X):

### Claim 20 (depends on 2)

A compound according to claim 2, wherein: R1 is hydrogen.

### Claim 21 (depends on 2)

A compound according to claim 2, wherein: R2 is halo or methoxy.

### Claim 22 (depends on 1)

A compound according to claim 1, wherein: R2 is chlorine or fluorine.

### Claim 23 (depends on 2)

A compound according to claim 2, wherein R1 and R2 form a five-membered ring containing one oxygen.

### Claim 24 (depends on 2)

A compound according to claim 2, wherein R1 and R2 form a six-membered ring containing two oxygens.

### Claim 25 (depends on 2)

A compound according to claim 2, wherein: R3 is hydrogen.

### Claim 26 (depends on 2)

A compound according to claim 2, wherein: R4 is halo.

### Claim 27 (depends on 2)

A compound according to claim 2, wherein: R6 is hydrogen.

### Claim 28 (depends on 2)

A method of treating or preventing hyperlipidemic conditions comprising the administration of an effective amount of a compound according to claim 2 to a mammal in need thereof.

### Claim 29 (depends on 2)

A method of treating or preventing atherosclerosis comprising the administration of an effective amount of a compound according to claim 2 to a mammal in need thereof.

### Claim 30 (depends on 2)

A method for treating or preventing Alzheimers' disease comprising the administration of an effective amount of a compound according to claim 2 to a mammal in need thereof.

### Claim 31 (depends on 2)

A method for treating or preventing cholesterol associated tumors comprising the administration of an effective amount of a compound according to claim 2 to a mammal in need thereof.

### Claim 32 (depends on 2)

A pharmaceutical formulation comprising a compound according to claim 2 in admixture with a pharmaceutically acceptable adjuvant, diluent and/or carrier.
